CJMB Callan JMB Inc.: רווח למניה ב-12 החודשים האחרונים

Callan JMB Inc (CJMB) is developing orthopedic technologies through alliances with surgical centers, establishing a foundation for M&A. This enables the release of cardiology risk monitoring systems for the early detection of attacks. Historical EPS YoY TTM dynamics on the GURU.Markets chart confirm the trend, where -80.50 represents the current metric. However, the high cost of components during pilot tests is temporarily constraining the startup's margin growth.

This indicator measures the rolling year net profit per share dynamics to determine capital generation efficiency. By analyzing the EPS growth rate over the last 12 months YoY, an investor assesses business sustainability and the risk of overpaying for the asset. Positive dynamics confirm operational reliability and the company's ability to scale profitability. For Callan JMB Inc (CJMB), this reflects the expansion of its medtech portfolio without a proportional increase in costs.